172 related articles for article (PubMed ID: 38803242)
1. Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.
Burghart L; Hofer BS; Halilbasic E; Simbrunner B; Staettermayer AF; Trauner M; Reiberger T
Aliment Pharmacol Ther; 2024 Jul; 60(1):107-108. PubMed ID: 38803242
[No Abstract] [Full Text] [Related]
2. Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis.
Ao X; Zeng Y; Wang X; Fan X
Aliment Pharmacol Ther; 2024 Jul; 60(1):105-106. PubMed ID: 38803269
[No Abstract] [Full Text] [Related]
3. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis.
Zhang H; Li S; Feng Y; Zhang Q; Xie B
Clin Exp Med; 2023 Sep; 23(5):1741-1749. PubMed ID: 36318376
[TBL] [Abstract][Full Text] [Related]
5. Novel Treatment Strategies for Primary Biliary Cholangitis.
Parés A
Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Primary Biliary Cholangitis including Transplantation.
Muzahim Y; Wakil A; Bassi M; Pyrsopoulos N
Clin Liver Dis; 2024 Feb; 28(1):103-114. PubMed ID: 37945152
[TBL] [Abstract][Full Text] [Related]
7. [New name and new treatments for primary biliary cholangitits].
Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
[TBL] [Abstract][Full Text] [Related]
8. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
Corpechot C; Chazouillères O; Rousseau A; Le Gruyer A; Habersetzer F; Mathurin P; Goria O; Potier P; Minello A; Silvain C; Abergel A; Debette-Gratien M; Larrey D; Roux O; Bronowicki JP; Boursier J; de Ledinghen V; Heurgue-Berlot A; Nguyen-Khac E; Zoulim F; Ollivier-Hourmand I; Zarski JP; Nkontchou G; Lemoinne S; Humbert L; Rainteau D; Lefèvre G; de Chaisemartin L; Chollet-Martin S; Gaouar F; Admane FH; Simon T; Poupon R
N Engl J Med; 2018 Jun; 378(23):2171-2181. PubMed ID: 29874528
[TBL] [Abstract][Full Text] [Related]
9. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
Abbas N; Culver EL; Thorburn D; Halliday N; Crothers H; Dyson JK; Phaw A; Aspinall R; Khakoo SI; Kallis Y; Smith B; Patanwala I; McCune A; Chimakurthi CR; Hegade V; Orrell M; Jones R; Mells G; Thain C; Thain RM; Jones D; Hirschfield G; Trivedi PJ
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1561-1570.e13. PubMed ID: 35961518
[TBL] [Abstract][Full Text] [Related]
10. [Fibrates].
Hara F; Yamazaki J
Nihon Rinsho; 2013 Sep; 71(9):1643-8. PubMed ID: 24205728
[TBL] [Abstract][Full Text] [Related]
11. Fibrate treatment for primary biliary cirrhosis.
Cuperus FJ; Halilbasic E; Trauner M
Curr Opin Gastroenterol; 2014 May; 30(3):279-86. PubMed ID: 24625898
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.
Wang C; Shi Y; Wang X; Ma H; Liu Q; Gao Y; Niu J
Front Immunol; 2022; 13():940688. PubMed ID: 35880178
[TBL] [Abstract][Full Text] [Related]
13. Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysis.
Shen N; Pan J; Miao H; Zhang H; Xing L; Yu X
Ann Palliat Med; 2021 Jul; 10(7):7697-7705. PubMed ID: 34353058
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification and treatment of primary biliary cholangitis.
Martínez J; Aguilera L; Albillos A
Rev Esp Enferm Dig; 2019 Jan; 111(1):63-70. PubMed ID: 30338693
[TBL] [Abstract][Full Text] [Related]
15. Editorial: The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply.
Mayo MJ; Vierling JM; Bowlus CL
Aliment Pharmacol Ther; 2024 Jan; 59(2):282. PubMed ID: 38153281
[No Abstract] [Full Text] [Related]
16. Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Authors' reply.
Sorda JA; González Ballerga E; Barreyro FJ; Daruich J
Aliment Pharmacol Ther; 2022 Jan; 55(2):249-250. PubMed ID: 34970761
[No Abstract] [Full Text] [Related]
17. [Primary biliary cholangitis].
Soret PA; Chazouillères O; Corpechot C
Rev Prat; 2021 Oct; 71(8):885-891. PubMed ID: 35147347
[TBL] [Abstract][Full Text] [Related]
18. Safety of fibrates in cholestatic liver diseases.
Carrion AF; Lindor KD; Levy C
Liver Int; 2021 Jun; 41(6):1335-1343. PubMed ID: 33751787
[TBL] [Abstract][Full Text] [Related]
19. New therapeutics in primary biliary cirrhosis: will there ever be light?
Invernizzi P; Gershwin ME
Liver Int; 2014 Feb; 34(2):167-70. PubMed ID: 24393247
[No Abstract] [Full Text] [Related]
20. Editorial: Itching to Know: Role of Fibrates in PBC.
Levy C; Lindor KD
Am J Gastroenterol; 2018 Jan; 113(1):56-57. PubMed ID: 29311728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
